- $3.43bn
- $3.33bn
- $3.96bn
- 98
- 70
- 80
- 96
Annual income statement for Plexus, fiscal year end - September 28th, USD millions except per share, conversion factor applied.
2020 October 3rd | 2021 October 2nd | 2022 October 1st | 2023 September 30th | 2024 September 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,390 | 3,369 | 3,811 | 4,210 | 3,961 |
| Cost of Revenue | |||||
| Gross Profit | 313 | 323 | 347 | 395 | 379 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,237 | 3,193 | 3,633 | 4,014 | 3,793 |
| Operating Profit | 153 | 176 | 178 | 196 | 168 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 135 | 160 | 158 | 161 | 130 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 116 | 139 | 138 | 139 | 112 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 117 | 139 | 138 | 139 | 112 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 117 | 139 | 138 | 139 | 112 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.76 | 4.86 | 4.94 | 5.84 | 4.81 |